Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crestor in symptomatic middle cerebral artery stenosis
NCT02041117Phase 4Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Feb 2014
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of rosuvastatin in Intracranial arterial stenosis (ICAS), sponsored by Beijing Tiantan Hospital. Primary endpoint: Change in the percentage of volume of MCA atherosclerosis plaque at 2 years. Started Feb 2014; status: completed.
02
Drugs
rosuvastatin
03
Conditions
Intracranial arterial stenosis (ICAS)
Beyond the preview
Go deeper on NCT02041117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02041117.